ArticleNature immunology2023
CD4
Open access · hybridAbstract read
In one paragraph
Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 37 citations in OpenAlex.
- Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4Cell reports methods · 2026Article
- Phagocytosis of necroptotic cells optimizes type 1 conventional dendritic cells for induction of a cytotoxic T-cell response.Cell death and differentiation · 2026Article
- PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Stem-like PD-1Journal for immunotherapy of cancer · 2026Article
- The AICL-KLRF1 axis supports CD4-CD8 T cell communication and cytokine competence in pre-exhausted CD8EMBO reports · 2026Article
- Article
- CD4Cancer biology & medicine · 2026Review
- γδ T cell-derived IL-4 initiates CD8Nature immunology · 2026Article
- Rewired type I IFN signaling is linked to age-dependent differences in COVID-19.Cell reports. Medicine · 2025Article
- Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8Immunity · 2025Article
- Virus-specific CD4+ T cells contribute to clearance of human metapneumovirus despite exhibiting an impaired phenotype.Journal of immunology (Baltimore, Md. : 1950) · 2025Article
- Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- An MHC-Related Gene's Signature Predicts Prognosis and Immune Microenvironment Infiltration in Glioblastoma.International journal of molecular sciences · 2025Article
- The High-Affinity IL-2 Receptor Affects White Matter Damage after Cerebral Ischemia by Regulating CD8 + T Lymphocyte Differentiation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025Article
- Aberrant expression of PYGB as a potential therapeutic target and its associations with immune cell infiltration in lung cancer.Frontiers in immunology · 2025Article
- Airway-resident memory CD4 T cell activation accelerates antigen presentation and T cell priming in draining lymph nodes.JCI insight · 2024Article
- Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.Heliyon · 2024Review
- CD4Cellular & molecular immunology · 2024Article
- Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection.Molecular biology reports · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
42 authors at 9 institutions in 2 countries.
Elise Gressier *Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia. elise.gressier07@gmail.com.ORCID http://orcid.org/0000-0003-0517-1610
Jonas Schulte-Schrepping *Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-7333-8924
Lev PetrovTranslational Immunology, Berlin Institute of Health (BIH) & Charité University Medicine, Berlin, Germany.
Sophia BrumhardInfectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Paula StubbemannInfectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Anna HillerInfectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Benedikt ObermayerBerlin Institute of Health at Charité, Universitätsmedizin Berlin, Core Unit Bioinformatics, Berlin, Germany.ORCID http://orcid.org/0000-0002-9116-630X
Jasper SpitzerInstitute of Innate Immunity, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-9696-2092
Tomislav KostevcTranslational Immunology, Berlin Institute of Health (BIH) & Charité University Medicine, Berlin, Germany.
Paul G WhitneyDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Annabell BachemDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Alexandru OdainicDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-2806-6904
Carolien van de SandtDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-4155-7433
Thi H O NguyenDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-9294-7693
Thomas AshhurstSydney Cytometry Core Research Facility, Charles Perkins Centre, Centenary Institute and University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0001-7269-7773
Kayla WilsonDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-2023-7964
Clare V L OatesDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Linden J GearingCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0003-3508-3056
Tina MeischelDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-0911-6574
Katharina HochheiserDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Marie GreyerDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Michele ClarkeDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Maike KreutzenbeckInstitute of Innate Immunity, University of Bonn, Bonn, Germany.
Sarah S GabrielDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-6359-485X
Wolfgang KastenmüllerWürzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-3835-1485
Christian KurtsInstitute of Experimental Immunology, University of Bonn, Bonn, Germany.
Sarah L LondriganDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0989-4971
Axel KalliesDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-6312-6968
Katherine KedzierskaDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-6141-335X
Paul J HertzogCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Eicke LatzInstitute of Innate Immunity, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0003-1488-5666
Yu-Chen E ChenMater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.
Kristen J RadfordMater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-6512-6323
Michael ChopinDepartment of Biochemistry, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Jan SchroederDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Florian KurthInfectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-3807-473X
Thomas GebhardtDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-3768-9468
Leif E SanderInfectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-0476-9947
Birgit SawitzkiTranslational Immunology, Berlin Institute of Health (BIH) & Charité University Medicine, Berlin, Germany.
Joachim L SchultzeLife and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
Susanne V SchmidtInstitute of Innate Immunity, University of Bonn, Bonn, Germany.
Sammy BedouiDepartment of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia. sbedoui@unimelb.edu.au.ORCID http://orcid.org/0000-0002-7443-0543
The University of Melbourne · AUUniversity of Bonn · DECharité - Universitätsmedizin Berlin · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEHudson Institute of Medical Research · AUThe University of Queensland · AUAustralian Regenerative Medicine Institute · AUThe University of Sydney · AUUniversity of Würzburg · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiviral CD8
Indexed as
Antiviral AgentsCOVID-19Antigen-Presenting CellsCalibrationCD40 AntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansInterferon-alphaAntiviral AgentsCD40 AntigensInterferon-alpha
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.